Table 4 Comparison of clinical characteristics at the second CAVI test and percent change in risk status from the first to the second CAVI test
Patients with persistently impaired CAVI | Patients with improved CAVI | P-value | |
|---|---|---|---|
The clinical characteristics at second CAVI test | |||
Systolic BP, mm Hg | 143±23 | 138±18 | 0.1 |
Diastolic BP, mm Hg | 85±9 | 83±8 | 0.08 |
Heart rate, b.p.m. | 69±12 | 68±11 | 0.7 |
Body mass index, kg m–2 | 24±3.5 | 23±3.0 | 0.3 |
Current smoker, n (%) | 19 (22) | 20 (22) | 0.9 |
LDL cholesterol, mg dl–1 | 104±27 | 96±26 | 0.1 |
HDL cholesterol, mg dl–1 | 53±11 | 51±14 | 0.5 |
Fasting glucose, mg dl–1 | 122±29 | 121±33 | 0.8 |
HbA1c, % | 6.4±0.9 | 6.0±0.6 | 0.006 |
CRP, mg l–1 | 1.0±1.1 | 1.2±1.3 | 0.4 |
Mean IMT, mm | 0.86±0.19 | 0.87±0.19 | 0.8 |
Second ba-PWV, m s–1 | 17.9±2.7 | 16.2±3.2 | <0.01 |
Second CAVI | 10.38±0.84 | 9.58±0.76 | <0.01 |
Percent change in risk status from the first to the second CAVI test | |||
Systolic BP, % | −4.1±23 | −3.8±25 | 0.9 |
Diastolic BP, % | −3.2±11 | −3.5±10 | 0.7 |
Heart rate, % | 0.6±13 | −2.0±14 | 0.1 |
Body mass index, kg m–2, % | −1.8±5.9 | −3.1±2.9 | 0.2 |
Current smoker, n | −6 | –11 | — |
LDL cholesterol, % | –9.8±20 | −11±32 | 0.9 |
HDL cholesterol, % | 2.1±7.3 | 2.3±7.7 | 0.8 |
Fasting glucose, % | –2.0±24 | −4.9±17 | 0.3 |
HbA1c, % | −1.3 | −2.0 | 0.6 |
CRP, % | −17±61 | −6.9±57 | 0.4 |
Δba-PWV, % | 5.3±11 | −5.4±13 | <0.001 |
Δ CAVI, % | 5.1±4.6 | −4.6±3.3 | <0.001 |
Δ IMT, % | 2.4±18 | 4.1±28 | 0.6 |
